Kobayashi M, Takezawa Y, Nakata S, Inoue M, Kurihara H, Kondo T, Kosaku N, Matsumoto K, Nakazato H, Yamanaka H
Department of Urology and Internal Medicine, Isesaki Municipal Hospital.
Nihon Hinyokika Gakkai Zasshi. 2000 Jan;91(1):1-7. doi: 10.5980/jpnjurol1989.91.1.
Screening by only prostate specific antigen (PSA) for prostate cancer was started since PSA had been added to mass screening as one of check lists in 1997 in Isesaki city, Gunma pref. We expected PSA screening to be introduced into other areas. We therefore studied how to perform a screening procedure for prostate cancer as well as discussed our result of the screening conducted lately.
1,382 out of 1,423 Isesaki citizens who took mass screening aged 40 to 64 were chosen. Regardless of age, men with a serum PSA level equal or larger than 4.1 ng/ml (Tandem R) were selected for second screening since we determined it was a cut-off level for further check-up. Of those men, 38 were requested for second screening and actually only 24 took it. All these men took PSA check-up again, furthermore 23 took transrectal examination (TRE) and/or transrectal ultra sonography (TRUS) except for one of them. The next screening was requested for sixteen of them. Prostate biopsy was conducted for all of them.
More old men took screening and were diagnosed prostate cancer. The findings derived from such diagnosis showed one of them aged 50 to 59 and six of them aged 60 to 64 had the cancer. Moreover, four out of twenty with PSA level ranging 4.1 to 10.0 ng/ml and all of three with PSA level over 20.0 ng/ml had the cancer. Five out of sixteen with a positive sign for further PSA check-ups had the cancer. All the three suspect of the cancer by TURS and DRE had prostate cancer. Two of seven with PSA negative showed suspicion of prostate cancer and had the cancer. No neo-adjuvant and total prostatectomy was conducted for four with 4.0 to 10.0ng/ml diagnosed T2N0 M0. One of them with PSA equal or over 20.0 ng/ml was diagnosed T3N0M0. After hormone therapy its PSA decreased to that equal or under 0.5 ng/ml. Total prostatectomy was conducted for it.
It is not proved that only PSA mass screening for prostatic cancer contributes to detect early cancer and better prognosis cure case. For the proof, it will be nessary that PSA mass screening is examined more people in the wide area. We conclude men aged 65 to 69 also should take PSA check-up based on epidemiological feature of prostatic cancer.
自1997年前列腺特异性抗原(PSA)作为检查项目之一被纳入群马县伊势崎市的大规模筛查以来,便开始了仅通过PSA筛查前列腺癌的工作。我们期望PSA筛查能推广到其他地区。因此,我们研究了如何进行前列腺癌筛查程序,并讨论了近期筛查的结果。
从1423名年龄在40至64岁接受大规模筛查的伊势崎市民中选取了1382人。无论年龄大小,血清PSA水平等于或高于4.1 ng/ml(串联R法)的男性被选作二次筛查对象,因为我们将此确定为进一步检查的临界值。在这些男性中,38人被要求进行二次筛查,实际只有24人接受了筛查。所有这些男性都再次进行了PSA检查,此外,除一人外,23人还接受了经直肠检查(TRE)和/或经直肠超声检查(TRUS)。其中16人被要求进行下一次筛查。对他们所有人都进行了前列腺活检。
接受筛查并被诊断为前列腺癌的老年人更多。此类诊断结果显示,其中一名50至59岁的男性以及六名60至64岁的男性患有癌症。此外,在PSA水平为4.1至10.0 ng/ml的20人中,有4人患有癌症,在PSA水平超过20.0 ng/ml的3人中,所有人都患有癌症。在进一步PSA检查呈阳性的16人中,有5人患有癌症。经TRUS和DRE怀疑患有癌症的3人都患有前列腺癌。在PSA阴性的7人中,有2人被怀疑患有前列腺癌并确诊。对于4名被诊断为T2N0M0且PSA为4.0至10.0 ng/ml的患者,未进行新辅助治疗和全前列腺切除术。其中一名PSA等于或高于20.0 ng/ml的患者被诊断为T3N0M0。经过激素治疗后,其PSA降至等于或低于0.5 ng/ml。对其进行了全前列腺切除术。
仅通过PSA大规模筛查前列腺癌是否有助于早期发现癌症并实现更好的预后治愈情况尚无定论。为了证实这一点,有必要在更广泛的区域对更多人进行PSA大规模筛查。根据前列腺癌的流行病学特征,我们得出结论,65至69岁的男性也应进行PSA检查。